Vivere Oncotherapies
PrivateLast Round
Seed
Jan 13, 2026
Total Funding Raised
$11.45M
Company Overview
Vivere Oncotherapies is a biotechnology company developing cancer therapies that activate the immune system to detect and selectively destroy cancer cells in tumors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivere Oncotherapies Comps
Public and private peers based on sector, stage, and business model.
Vivere Oncotherapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 13, 2026 |
Vivere Oncotherapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| California Innovation Fund | Pre Seed |
| Freeflow Ventures | Seed, Pre Seed |
| Pillar VC | Pre Seed |
| Berkeley Frontier Fund | Seed, Pre Seed |
Vivere Oncotherapies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivere Oncotherapies's valuation, stock price, and market status.
